Objective: Since raised levels of endothelin-1 (ET-1) have been detected in the human coronary sinus following percutaneous transluminal angioplasty (PTCA) we investigated the role of ET-1 in the etiology of vascular restenosis. Methods: Balloon angioplasty of coronary arteries was performed in pigs and the animals were treated with placebo or the endothelin (ET ) receptor antagonist LU 135252 antagonists in reducing the degree of restenosis following vascular injury.
Introduction
suggesting that this peptide plays a pathological role in vascular restenosis [3] . The long-term efficacy of percutaneous transluminal There is evidence that exogenous administration of ET-1 coronary angioplasty (PTCA) is limited by the high causes a dose-dependent augmentation of angioplasty-inincidence of vascular stenosis following this procedure.
duced neointimal formation of the rat carotid artery [4] . The damaging effect of PTCA on vascular endothelial Recently it has also been shown that ET receptor antagocells, and underlying tissue, is known to play a significant nists reduce neointimal formation in this animal model, role in neointimal formation, via the release of a variety of suggesting that endogenous ET-1 is involved in angiopneurohumoral compounds. Endothelin-1 (ET-1), a potent lasty-induced lesion formation in the rat [5, 6] . These endothelium-derived vasoconstrictor peptide [1] also posstudies have used a combination of morphometric analysis sesses mitogenic activity on various cells types, including and vascular smooth muscle cell (VSMC) culture / 3 vascular smooth muscle cells [2] . Levels of ET-1 are [ H]thymidine incorporation assay to study the potential elevated in the human coronary sinus following PTCA, proliferative role of ET-1 in neointimal formation in the rat carotid artery following balloon angioplasty. Similar results have recently been described following oral adminis- tration of the ET receptor antagonist LU 135252 [7] . Here chosen according to Ref. [7] where a selective blockade of A we have performed PTCA on porcine epicardial coronary ET receptors was achieved. The cardiovascular effects of A arteries and examined the effect of the ET receptor LU 135252 were investigated in pigs after administration A antagonist, LU135252, on subsequent neointima formation of 10 mg / kg i.v. This dose had no effect on blood pressure in these animals. Vascular stenosis was assessed mor-(MK, data on file). As the peak plasma concentration phometrically while the localization of ET-1 and its reached after 10 mg / kg i.v. was higher than after 30 receptors (ET / ET ) was studied using a combination of mg / kg p.o. given with the feed it was assumed that no A B immunohistochemistry and in vitro autoradiography. haemodynamic effects would occur in this study.
Tissue collection 2. Methods
Twenty eight days after balloon angioplasty the animals Twelve male domestic pigs, 8-9 weeks old weighing were anaesthetised, the chest opened and the heart re-22-29 kg were used. The animals were acclimatized for at moved. The dilated coronary artery segments, as deterleast 1 week prior to the experiment. Animal care and mined from X-ray pictures of exact balloon position and husbandry conformed with the Guide for the Care and Use the adjacent non-injured vessel segments, were then careof Laboratory Animals (NIH Publication No. 85-23, fully dissected from the epicardial surface and transferred revised 1985), were in compliance with EC directive into phosphate-buffered saline and tissue tek injected into 86 / 609 and the study was approved by the appropriate the lumen of the artery. After freezing, the artery was local authority.
divided into three injured and one proximal non-injured transverse segments (5 mm each) and stored at 2708C 2.1. Balloon angioplasty until use. Additionally, one non-injured segment of the same artery was removed (see Section 2.5). Three 10-mm transverse sections from each injured (Judkin left, powerbase 8F, ACS:mandrin) was then advessel segment were cut in a cryostat, thaw-mounted onto vanced via the aortic root into the left anterior descending microscope slides and stained with haematoxylin and coronary artery (LAD) under X-ray guidance. The balloon eosin. Non-injured control segments were obtained from catheter (RX Elipse 0.014, ACS) was positioned in the the same animals and the same vessel proximal to the middle portion of the vessel using a 0.0140 guide wire balloon injury. In each section, the cross sectional area of (Galeo, Biotronic, Berlin). After confirming its position lumen, media and neointima and total vessel was deunder X-ray control the balloon catheter was inflated twice termined by a person who was blinded with regard to the at 10 atm for 30 s. The balloon to artery ratio was 3 mm to treatment groups using digital morphometry (cardio 200). 1.6-2 mm. After deflating the balloon the catheter was Ratios of neointima to media area and to total vessel area withdrawn and an additional angiogram made to verify the were calculated. lesion. Additionally, the degree of vessel injury at the angioplasty site was shown to be the same for both groups 2.5. In vitro autoradiography by histological examination post mortem.
ET-1 receptors were identified as described previously 2.2. Drug administration [8] . Briefly, 10-mm serial transverse sections of injured and non-injured segments of the LAD were cut in a cryostat at Before PTCA the pigs were randomised into two approximately 2208C and thaw-mounted onto gelatinised groups, one receiving 30 mg / kg / day LU 135252 orally microscope slides. Endogenous peptide levels were re-(mixed into mashed potatoes) or controls. Immediately duced by preincubating sections in 50 mmol / l Tris-HCl prior to balloon inflation the animals in the respective buffer, pH 7.4, for 15 min at 228C. Slide-mounted tissue groups received either 3 mg / kg LU 135252 or 0.9% NaCl was then incubated in Tris-HCl buffer (plus 5mmol / L intravenously. Oral treatment was started on the first day MgCl , 0.2% bovine serum albumen and 100 kIU / ml after PTCA and continued for 4 weeks. LU 135252 (1)- was found up to 10 mM. The dose of 30 mg / kg / day was Tyr, [9, 10] (5N-Acetyl-[Ala ]-endothelin-1 (6-21), [10, 11] ) 100-neointima / total area of both groups were averaged and 150 pmol / l, specific activity of both compounds 2000 described with summary statistics. Observed data of the Ci / mmol / l; Amersham). The degree of non-specific binddifferent tissue areas were analyzed with a multiway ing for each radioligand was established by incubating analysis of variance (factors drug (15control, 25LU alternate slides in the presence of 1 mmol / l unlabelled 135252), animal (1-5 in the control group and 5-12 in the ET-1 (Bachem Fine Chemicals, Basel, Switzerland). After LU 135252 group), location of sections (1-3), repetition incubation tissue was washed (two times 10 min) in (1-3)), with the factors animal, location, repetition nested Tris-HCl buffer (48C), dipped in ice-cold glass-distilled within the drug factor. All statistical analysis was perwater, and dried in a stream of cold air.
formed with SAS version 6.12 (SAS Institute Inc, Cary, Autoradiographs were generated by exposing incubated NC). 3 tissue to Hyperfilm H (Amersham International, BuckinCalculated receptor densities in injured and non-injured ghamshire, UK) in X-ray cassettes for up to 4 days at 48C. medial tissue were averaged and described with a general After this period films were processed according to the linear model (ANOVA) using the same SAS software. manufacturer's instructions. Receptor binding was assessed Differences were considered significant at the level P, densitometrically on a Kontron VIDAS imaging system 0.05. (Kontron Ltd, Thame, Oxfordshire, UK) and binding 125 calculated from curves generated by [ I] microscales 3. Results (Amersham) that were co-exposed with slide-mounted tissue. Binding was localised at the cellular level by
In control animals histological examination revealed dipping incubated sections in molten nuclear emulsion neointima formation within segments of LAD one month (Hypercoat LM-1, Amersham) and exposing for up to 8 following PTCA. The neointima was evident as a prodays at 48C in light-proof boxes. Emulsion was processed nounced eccentric layer, composed largely of smooth and underlying tissue stained with Mayer's haematoxylin muscle cells (positive anti-alpha-actin immunoreactivity), and eosin for histological examination [12] .
underlying a ruptured internal elastic lamina ( Fig. 1 ), often at more than one site. Table 1 shows the observed section 2.6. Immunohistochemistry means and summary statistics for the different areas, obtained over all animals and sections included in the Immunohistochemistry was performed on selected seccontrol and LU 135252 group, Table 2 the data of nontions of coronary artery using the Vector avidin-biotin injured LAD segments, and Table 3 the ANOVA results. complex method (ABC) (Vector Laboratories, Peter-
The total area of non-injured segments was slightly larger borough, UK). Briefly, sections were fixed in acetone, as these segments were located proximally to the injury rinsed, blocked in 20% normal goat serum in Tris-buffered site.. The proliferative response (expressed as neointimal saline and incubated for 20 h at 108C in monoclonal area) in injured segments was significantly reduced in anti-ET-1 [13, 14] (generously provided by Dr. A.C.M.
animals receiving LU 135252 (Table 1 and Figs. 1 and 2). Ong) (diluted 1:500). Tissue was then processed with Although the medial area was slightly larger in LU 135252 biotinylated goat anti-mouse IgG and Vector's ABC kit, treated pigs, the neointima / media ratio was still reduced developed with either 3,39-diaminobenzidine or Vector red compared to the control group (0.4360.30 vs. 0.8760.36, and counterstained with Mayer's haematoxylin. P,0.001). The observed differences in luminal area Smooth muscle cells were identified using an anti-alphabetween treatment groups were statistical significant. In smooth-muscle actin antibody (Dako Laboratories, High order to detect any possible influence on vascular remodelWycombe, Buckinghamshire, UK). Controls were estabing we further investigated the differences in total vessel lished using an irrelevant antibody and no primary antiarea and the ratio neointima to total vessel area in injured body.
segments (Table 1) . No significant difference with respect VSMC nuclei counts have been carried out on five fields to the total area between control and treatment group was per vessel section (within a grid measuring 100350 mm) detected (Table 1 ). The index neointima / total area was on 4-6 sections from injured and non-injured segments statistically significant smaller in LU 135252-treated pigs from five animals (at 3200 magnification). The compared to placebo-treated pigs indicating a significant mean6S.E.M. of 20-30 measurements per [injured / nonpositive effect of ET receptor blockade after PTCA
A injured] vessel was calculated from n5five animals: .250 (Tables 1 and 3 ). The observed differences between the counts).
pigs were significant as well as the observed differences between section areas. No statistical significant differences 2.7. Statistical analysis between the three replicate measurements made on each segment of all areas (Tables 1 and 3) were observed.
125
Mean section values of lumen, media, neointima, total The dense [ I]-ET-1 binding to all vessel sections vessel area as well as the indexes neointima / media and (Fig. 3 ) that was markedly reduced where tissue was There is a damaged internal elastic lamina (arrowhead) but neointima formation is markedly reduced. ADV, adventitia. Values for area of neointima, media, lumen and total vessel are given in mm (data from three injured segments each from five control and seven drug-treated pigs, measurements of the three replications of each section were averaged before analysis. N5total number of segment, S.E.M.5standard error). The ratios of neointima / media and neointima / total vessel area were calculated. [ I]-BQ3020 binding; mean6S.E.M. of n55 pigs).
Discussion Autoradiographs, obtained by coating slide-mounted sections with nuclear emulsion (high-resolution), con-
The vasoconstrictor peptide ET-1 also has a potent firmed that there was dense binding of all radioligands to mitogenic action on vascular smooth muscle cells [15] . the tunica media (Fig. 6) and that, at this region, ET Originally isolated from cultured porcine endothelial cells A binding was stronger than ET binding (Figs. 7a,b) . [1] , there is also evidence that ET-1 is produced by smooth B Histology of non-injured segments of LAD confirmed that muscle cells in culture [16] , indeed it has been subsequentluminal endothelial cells were intact and in close apposily shown that the proliferative responsiveness of human tion to an undamaged internal elastic lamina (Fig. 7a) . In VSMCs correlates with ET receptor density [17] . ET-1-these segments binding was essentially uniform throughout immunoreactivity is present in atherosclerotic plaque of the vessel wall. All injured segments of control animals human blood vessels [18, 19] and there is abundant evishowed the formation of neointima underlying a ruptured dence that this peptide plays a promitogenic role in a internal elastic lamina (Figs. 6 and 7b ). The damage to the variety of vascular diseases [2] . Apart from a potential role internal elastic lamina was often to several sites and, on in the pathophysiology of coronary artery disease, ET-1 occasions, extended to the external elastic lamina.
has been implicated in the pathogenesis of restenosis following PTCA. Raised circulating immunoreactive ET-1 has been demonstrated in patients following this procedure [3] and there is recent evidence of a time-dependent increase in ET-1, ET-3, ECE, ET and ET mRNA those 'downstream' from atherosclerotic lesions or sites of vascular damage, for example distal segments of epicardial coronary arteries and myocardial microvessels [10] . There is experimental evidence that exogenous administration of ET-1 augments neointima formation after balloon catheter injury of the rat [4] ; however, as these data are of necessity based on a very small number and have not yet been seen in any other species but rat the relevance for other animal models and especially so for man remains PTCA-induced neointima formation [7] . Whilst the rat carotid artery serves as a useful exgioplasty there was a striking degree of adventitial reperimental model for studying the effects of vascular modelling one month post-PTCA, a phenomenon described injury, a porcine coronary artery model has been described following other forms of vascular injury [22] . Examination that mimics the pathology of human restenosis [21, 22] .
of the 'neoadventitia' of injured vessels revealed the This model is closer to the human pathology then anything presence of inflammatory cells (as described in porcine found in rodent models; however, it still has at least two vein grafts, [25]), regions of neovascularization, similar to methodological shortcomings. One of them may be the that observed following occlusion of the adventitial vasa difference regarding arterial wound healing, scar formavasorum [8] and a pronounced paravascular neoinnervation tion, and thus remodelling and 'recoil' between pig and
[26]. These regions exhibited ET-1-like immunoreactivity human coronary arteries [23] . The second difference of and / or ET 'receptors' and are the focus of ongoing studies. course relates to the difference in the health state: Whereas
The localization of immunoreactive ET-1 [14, 18, 19 ] and the pigs used in the present study and indeed in most other ET-1 receptors [8, 10] on human epicardial coronary arstudies published with different drugs are relatively young teries has been reported. Here, using a combination of and not suffering from atherosclerosis [24] , the opposite immunohistochemistry and in vitro autoradiography, we holds true for patients. This may also account for at least have identified ET-1 and its receptors within segments of some of the differences in arterial healing discussed above injured and non-injured porcine coronary artery following and certainly necessitates caution in any prognosis as to balloon angioplasty. the relevance of the treatment for clinical use.
Previous studies have shown that both mixed and ET A The main purpose of the present study was to determine antagonists reduce angioplasty-induced neointima formathe effect of the ET antagonist, LU 135252, on PTCAtion [4, 5, 27] . Here we present novel data indicating that A induced neointima formation in porcine coronary arteries. there is a marked increase in ET receptor binding to medial Apart from neointimal hyperplasia following balloon anvascular smooth cells following angioplasty and that this Since the mitogenic action of ET-1 on VSMCs has been shown to correlate with ET receptor density [17] , ET A receptor blockade may also have an antiproliferative effect on those medial VSMCs involved in neointima formation. ET binding, predominantly to ET receptors, was also A evident within the neointima of control animals and these regions of myointimal hyperplasia also demonstrated strong ET-1-like immunoreactivity (both associated with VSMCs). Restenosis, following balloon injury, involves the migration and proliferation of VSMCs from the media (contractile phenotype) to the intima (synthetic phenotype) with subsequent neointima formation [28] . Apart from ET-1 release, due to endothelial injury following PTCA, the rupture of the internal elastic lamina and mechanical stimulation of the media is also likely to lead to ET-1 release from VSMCs. Our results suggest that this peptide acts in an autocrine / paracrine fashion in this porcine model of coronary restenosis. Apart from any transient vasoconstrictor action, locally-generated ET-1 (from the endothelium and VSMCs) may also stimulate proliferation of VSMCs, leading to neointima formation and eventual vessel occlusion. ET-1-stimulated VSMC proliferation and neointima formation has been shown to be blocked by ET-1 antagonists [29] . Early reports on the effect of ET antagonists on reducing experimental neointima formation utilised mixed ET / ET antagonists [5, 30, 31] and subsequent in vitro A B observations indicated that both receptor subtypes were associated with the ability of ET-1 to promote VSMC antagonists may be species-dependent (ET in the rat A injured and non-injured segments from five control and seven drug- [6, 30, 31] ; ET in the rabbit [32, 33] the injured vessel segments exhibited a marked neointima percent independent of the dose tested [34] . In our and medial thickening 4 weeks post-PTCA. ET / ET laboratory a similar reduction was achieved in the same A B binding to the tunica media of injured segments was model, again applying 30 mg / kg / day LU 135252 for 4 significantly greater than binding to non-injured regions of weeks [24] . the LAD. This increased binding is likely to reflect an Our data presented here as well as the stent data increase in membrane 'receptors' since, although there was discussed above may be more relevant to the human evidence of medial thickening, VSMC density (i.e. cells situation since they have been obtained using porcine 2 per mm ) of injured segments was unaltered. Interestingly, epicardial coronary arteries, rather than rat / rabbit aorta or apart from reducing neointima formation following PTCA, carotid artery. The histological changes induced by balloon the elevated level of medial ET binding to injured segangioplasty in the pig are similar to those seen in patients ments was normalized in animals receiving LU 135252.
following PTCA [21, 22] . However, as discussed above, the lack of atherosclerotic disease and possibly differences in in the media and neointima of injured segments of the arterial healing and remodelling needs to be taken into coronary artery suggests that these represent sites where account. Nevertheless the predominance of ET receptors the ET antagonist, LU 135252, acts to reduce neointima A A
